Is Hikma A Multinational Company?
Hikma is a multinational pharmaceutical company with headquarters in the United Kingdom. We are a global company with local presence in the United States, Middle East, and Europe and offer a wide range of generic medicines to our customers.
Where Is Hikma Pharmaceuticals Located?
Hikma Pharmaceuticals plc is a multinational pharmaceutical company based in London, UK, that produces generic and non-branded pharmaceutical products under license.
Is Hikma A Good Stock To Buy?
Based on no buy ratings, four hold ratings, and no sell ratings, the consensus rating for Hikma Pharmaceuticals is Hold, with an average rating score of 2.00.
What Does Hikma Do?
We create, manufacture, and market generic pharmaceutical products, both branded and unbranded.
What Does Hikma Sell?
We create, manufacture, and market generic pharmaceutical products, both branded and unbranded.
Where Are Hikma Pharmaceuticals Manufactured?
Europe: We have high-quality manufacturing facilities in Germany, Italy, and Portugal that produce injectable medicines and ship them to the United States, the Middle East, and Europe.
How Many Products Hikma Have?
POWERED BY PARTNERSHIP Our dedicated Hikma team is always available to assist you in times of need because we are a reliable partner and source of high-quality medicines with more than 670 products as of December 31, 2021.
- Breaking Down the Recent Vesuvius Share Price Rally on the NSE - March 23, 2023
- Understanding the Factors Driving Vikas Multicorp’s Share Price on BSE - March 23, 2023
- Analyzing the Major Factors Affecting National Express Share Price in 2021 - March 23, 2023